- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Benfotiamine.
Displaying page 1 of 1.
EudraCT Number: 2013-001058-85 | Sponsor Protocol Number: WOE_2013_SB | Start Date*: 2013-07-30 | |||||||||||
Sponsor Name:Wörwag Pharma GmbH & Co. KG | |||||||||||||
Full Title: EFFECTS OF BENFOTIAMINE ON INTRAEPIDERMAL NERVE FIBER DENSITY (IENFD) AND DIABETIC NEUROPATHY IN SUBJECTS WITH SENSORIMOTOR DIABETIC POLYNEUROPATHY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, ... | |||||||||||||
Medical condition: Diabetic neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001755-19 | Sponsor Protocol Number: BENFO-1 | Start Date*: 2007-11-15 |
Sponsor Name:UMCG | ||
Full Title: A double-blind Clinical Trial of Benfotiamine Treatment in Diabetic Nephropathy | ||
Medical condition: Diabetic nephropathy is a serious complication of diabetes mellitus, which is the leading cause of end-stage renal disease (ESRD). Benfotiamine has been shown to reduce diabetic nephropathy and ret... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000799-15 | Sponsor Protocol Number: 04-04074 | Start Date*: 2004-09-09 |
Sponsor Name:Aker University Hospital | ||
Full Title: DOES BENFOTIAMINE SUPPLEMENTATION REDUCE SERUM LEVELS OF ADVANCED GLYCATION END PRODUCTS AND BIOCHEMICAL MARKERS OF VASCULAR DYSFUNCTION IN TYPE 1 DIABETES? | ||
Medical condition: Type 1 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003054-16 | Sponsor Protocol Number: DDZ-BOND-2017 | Start Date*: 2018-07-27 | |||||||||||
Sponsor Name:Wörwag Pharma GmbH & co. KG | |||||||||||||
Full Title: Randomized double-blind, placebo-controlled parallel group study over 12 months to assess the effects of treatment with benfotiamine on morphometric, neurophysiological, and clinical measures in ty... | |||||||||||||
Medical condition: diabetic polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
